Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aurelius Health Group vs FitRx

Aurelius Health Group
Graded #311

Lower grade

vs+5.400000000000006
FitRx
Graded #196

Higher grade

The verdict

FitRx takes it — 66.2/100 to 60.8/100.

FitRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitRx +9
54
63
Dose & formulationFitRx +13
52
65
Clinical oversightEven
76
76
Labs & monitoringAurelius Health Group +10
63
53
FulfillmentFitRx +27
61
88
Contract termsAurelius Health Group +14
61
47
Aurelius Health Group · left barFitRx · right bar

The numbers

MetricAurelius Health GroupFitRx
WeighScore60.8/10066.2/100
GradeCC
Scorecard rank#311#196
SemaglutideNot disclosed$151/mo (quarterly plan, compounded)
Tirzepatide$199/mo (microdose tier, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Aurelius Health Group

Graded #311 · C

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Where it loses points

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose programme and nothing else — no labelled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labelled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product
FitRx

Graded #196 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • LegitScript certified
  • All 50 states + DC coverage
  • Compounded semaglutide from $151/mo quarterly for uninsured patients

Where it loses points

  • Insurance coordination may not work for all plans
  • Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
  • Compounded option is semaglutide only — no compounded tirzepatide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard